Key result
Type 2 diabetes did not alter myocardial glucose uptake in nonstenotic or stenotic regions in CAD patients with preserved LVEF.
Why the study?
Does type 2 diabetes induce myocardial insulin resistance, and does acute hyperinsulinemia alter myocardial perfusion in patients with coronary artery disease and preserved LVEF?
Cross-Sectional (n=27)
Does type 2 diabetes induce myocardial insulin resistance, and does acute hyperinsulinemia alter myocardial perfusion in patients with coronary artery disease and preserved LVEF?
Myocardial insulin resistance to glucose uptake is not an inherent feature in T2DM patients with preserved LVEF, and acute insulin exposure does not cause coronary vasodilation in CAD patients regardless of T2DM status.
Answers are grounded in this paper and cite their sources.
Myocardial glucose uptake appears preserved regardless of T2DM in CAD with preserved LVEF; leaves open whether resistance emerges in reduced LVEF or other phenotypes.
BACKGROUND AND HYPOTHESIS: Myocardial insulin resistance (IR) is a feature of coronary artery disease (CAD) with reduced left ventricular ejection fraction (LVEF). Whether type 2 diabetes mellitus (T2DM) with CAD and preserved LVEF induces myocardial IR and whether insulin in these patients acts as a myocardial vasodilator is debated. METHODS: We studied 27 CAD patients (LVEF > 50%): 12 with T2DM (CAD+DM), 15 without T2DM (CAD-NoDM). Regional myocardial and skeletal glucose uptake, myocardial and skeletal muscle perfusion were measured with positron emission tomography. Myocardial muscle perfusion was measured at rest and during hyperemia in nonstenotic and stenotic regions with and without acute hyperinsulinemia. RESULTS: Myocardial glucose uptake was similar in CAD+DM and CAD-NoDM in both nonstenotic and stenotic regions [0.38 +/- 0.08 and 0.36 +/- 0.11 micromol/g.min; P value nonsignificant (NS)] and (0.35 +/- 0.09 and 0.37 +/- 0.13 micromol/g.min; P = NS). Skeletal glucose uptake was reduced in CAD+DM (0.05 +/- 0.04 vs. 0.10 +/- 0.05 micromol/g.min; P = 0.02), and likewise, whole-body glucose uptake was reduced in CAD+DM (4.0 +/- 2.8 vs. 7.0 +/- 2.4 mg/kg.min; P = 0.01). Insulin did not alter myocardial muscle perfusion at rest or during hyperemia. Insulin increased skeletal muscle perfusion in CAD-NoDM (0.11 +/- 0.03 vs. 0.06 +/- 0.03 ml/g.min; P = 0.02), but not in CAD+DM (0.08 +/- 0.04 and 0.09 +/- 0.05 ml/g.min; P = NS). CONCLUSION: Myocardial IR to glucose uptake is not an inherent feature in T2DM patients with preserved LVEF. Acute physiological insulin exposure exerts no coronary vasodilation in CAD patients irrespective of T2DM.
No takes yet. Share an insight, caveat, or question.
Søndergaard et al. (2006) conducted a cross-sectional in Coronary artery disease (n=27). Type 2 diabetes mellitus vs. No type 2 diabetes was evaluated on Myocardial glucose uptake in nonstenotic regions (micromol/g.min) (p=NS). Type 2 diabetes did not alter myocardial glucose uptake in nonstenotic or stenotic regions in CAD patients with preserved LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: